Analysts Set Cognex Corporation (NASDAQ:CGNX) Target Price at $72.31

Cognex Corporation (NASDAQ:CGNXGet Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen analysts that are currently covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $75.6429.

Several equities research analysts have issued reports on the stock. The Goldman Sachs Group reissued a “buy” rating and issued a $91.00 price objective on shares of Cognex in a research report on Friday, August 7th. Stephens lifted their price target on shares of Cognex from $65.00 to $75.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Barclays reiterated an “overweight” rating and issued a $80.00 price target (up from $75.00) on shares of Cognex in a report on Monday. Seaport Research Partners set a $75.00 price objective on shares of Cognex in a research note on Tuesday, May 26th. Finally, JPMorgan Chase & Co. raised shares of Cognex from a “neutral” rating to an “overweight” rating and raised their target price for the company from $65.00 to $75.00 in a research report on Tuesday, May 26th.

View Our Latest Stock Analysis on CGNX

Insider Buying and Selling

In other Cognex news, VP Darren Marc Long sold 20,252 shares of the company’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the completion of the sale, the vice president owned 3,990 shares in the company, valued at $264,696.60. This represents a 83.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cognex

A number of hedge funds have recently made changes to their positions in CGNX. State of Michigan Retirement System boosted its position in Cognex by 0.5% during the first quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company’s stock valued at $1,952,000 after purchasing an additional 200 shares in the last quarter. Personal CFO Solutions LLC raised its holdings in Cognex by 3.2% in the first quarter. Personal CFO Solutions LLC now owns 6,793 shares of the scientific and technical instruments company’s stock worth $333,000 after purchasing an additional 212 shares in the last quarter. World Investment Advisors raised its holdings in Cognex by 3.7% in the first quarter. World Investment Advisors now owns 6,073 shares of the scientific and technical instruments company’s stock worth $298,000 after purchasing an additional 214 shares in the last quarter. Quadrant Capital Group LLC lifted its position in shares of Cognex by 1.0% during the fourth quarter. Quadrant Capital Group LLC now owns 22,907 shares of the scientific and technical instruments company’s stock valued at $824,000 after buying an additional 234 shares during the last quarter. Finally, Essential Partners LLC lifted its position in shares of Cognex by 12.5% during the first quarter. Essential Partners LLC now owns 2,153 shares of the scientific and technical instruments company’s stock valued at $105,000 after buying an additional 239 shares during the last quarter. 88.12% of the stock is currently owned by hedge funds and other institutional investors.

Cognex Stock Up 1.5%

CGNX stock opened at $61.59 on Friday. Cognex has a twelve month low of $34.60 and a twelve month high of $72.88. The firm has a market cap of $10.36 billion, a price-to-earnings ratio of 59.80 and a beta of 1.49. The business’s fifty day simple moving average is $64.77 and its two-hundred day simple moving average is $57.90.

Cognex (NASDAQ:CGNXGet Free Report) last issued its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.03. The firm had revenue of $291.26 million during the quarter, compared to analyst estimates of $292.10 million. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The business’s revenue was up 16.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.25 earnings per share. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. Research analysts expect that Cognex will post 1.68 EPS for the current year.

Cognex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be issued a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Thursday, August 20th. Cognex’s dividend payout ratio (DPR) is presently 33.01%.

Cognex Company Profile

(Get Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Featured Stories

Analyst Recommendations for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.